Literature DB >> 3305411

Relevance of host-derived and bacterial factors in Pseudomonas aeruginosa corneal infections.

K P Steuhl, G Döring, A Henni, H J Thiel, K Botzenhart.   

Abstract

Two pathogenic mechanisms of Pseudomonas aeruginosa corneal infections are discussed, one involving bacterial exoenzymes, the other involving polymorphonuclear leukocyte (PMN)-derived lysosomal enzymes. The objective of the present study was (1) to show the relative importance of the two mechanisms and (2) to evaluate the effect of active immunization against P. aeruginosa exoenzymes on ocular damage. Rabbits were immunized against P. aeruginosa alkaline protease (AP) or elastase (Ela) and challenged with the respective enzymes. Corneal damage was studied by light photography (LP). In another group, rabbits were immunized against AP, Ela and exotoxin A (ExoA) and challenged with P. aeruginosa strains PA01 or PA103. Corneal damage was studied with LP, light microscopy, and electron microscopy. Immunized animals were totally protected against intracorneal inoculation of P. aeruginosa proteases. Twelve hr and 24 hr after challenge with whole bacteria, immunized rabbits revealed less corneal damage than non-immunized animals. However, after 48 hr corneal damage (ie severe corneal ulceration) was comparable in both groups. The study suggests that corneal damage involving lysosomal enzymes from stimulated PMN is more important after bacterial infection than direct damage by P. aeruginosa exoenzymes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3305411

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  28 in total

1.  Expression of interleukin-6 in the cornea in response to infection with different strains of Pseudomonas aeruginosa.

Authors:  N Cole; S Bao; M Willcox; A J Husband
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Inflammatory responses of corneal epithelial cells to Pseudomonas aeruginosa infection.

Authors:  Jing Zhang; Xin-Yi Wu; Fu-Shin X Yu
Journal:  Curr Eye Res       Date:  2005-07       Impact factor: 2.424

Review 3.  In vivo imaging of corneal inflammation: new tools for clinical practice and research.

Authors:  Dimosthenis Mantopoulos; Andrea Cruzat; Pedram Hamrah
Journal:  Semin Ophthalmol       Date:  2010 Sep-Nov       Impact factor: 1.975

4.  Early cytokine and chemokine gene expression during Pseudomonas aeruginosa corneal infection in mice.

Authors:  K A Kernacki; D J Goebel; M S Poosch; L D Hazlett
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

5.  High-mobility group box 1: a novel target for treatment of Pseudomonas aeruginosa keratitis.

Authors:  Sharon McClellan; Xiaoyu Jiang; Ronald Barrett; Linda D Hazlett
Journal:  J Immunol       Date:  2015-01-14       Impact factor: 5.422

6.  Proinflammatory cytokine deficiency and pathogenesis of Pseudomonas aeruginosa keratitis in aged mice.

Authors:  J A Hobden; S A Masinick; R P Barrett; L D Hazlett
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

7.  Kinetics of serum, tear, and corneal antibody responses in resistant and susceptible mice intracorneally infected with Pseudomonas aeruginosa.

Authors:  M J Preston; K A Kernacki; J M Berk; L D Hazlett; R S Berk
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

8.  Role of EGFR transactivation in preventing apoptosis in Pseudomonas aeruginosa-infected human corneal epithelial cells.

Authors:  Jing Zhang; Hui Li; Jinzhao Wang; Zheng Dong; Shahzad Mian; Fu-Shin X Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-08       Impact factor: 4.799

9.  Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treated with ciprofloxacin, prednisolone, and flurbiprofen.

Authors:  J A Hobden; J M Hill; L S Engel; R J O'Callaghan
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

10.  Galectin-1-mediated suppression of Pseudomonas aeruginosa-induced corneal immunopathology.

Authors:  Amol Suryawanshi; Zhiyi Cao; Thananya Thitiprasert; Tanveer S Zaidi; Noorjahan Panjwani
Journal:  J Immunol       Date:  2013-05-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.